LIMB GIRDLE MUSCULAR DYSTROPHY

Clinical trials for LIMB GIRDLE MUSCULAR DYSTROPHY explained in plain language.

Never miss a new study

Get alerted when new LIMB GIRDLE MUSCULAR DYSTROPHY trials appear

Sign up with your email to follow new studies for LIMB GIRDLE MUSCULAR DYSTROPHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 4 Completed 1 Terminated 2

First human test of gene therapy for rare muscle disease begins

Disease control Recruiting now

This study is testing the safety of a single-dose gene therapy called AB-1003 in adults with limb-girdle muscular dystrophy type 2I/R9, a rare genetic muscle disorder. Researchers will give increasing doses to small groups of participants to check for side effects. The goal is to…

Matched conditions: LIMB GIRDLE MUSCULAR DYSTROPHY

Phase: PHASE1, PHASE2 • Sponsor: AskBio Inc • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

LIMB GIRDLE MUSCULAR DYSTROPHY

Get alerted when new LIMB GIRDLE MUSCULAR DYSTROPHY trials appear

First human test of gene therapy for rare muscle disease begins